First Tracks Biotherapeutics, Inc.
TRAXLatest QuantConomy context for TRAX: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
Asset class
asset
Primary venue
—
Recent signals
0
SEC filings
20
Asset profile
First Tracks Biotherapeutics, Inc.
QuantConomy has a structured record for TRAX. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- TRAX
- Name
- First Tracks Biotherapeutics, Inc.
- Coverage
- 0 market/data records
Latest signal rows
Recent signals for TRAX
Scored rows are pulled from the same signal API used by the digests.
No recent scored signal rows were returned for TRAX.
Recent insider transactions
Buys, last 90d
0
Sells, last 90d
0
Rows
20
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| May 12, 2026 | Orwin John A | Director | grant | 2,500 | — | — | 4 on EDGAR |
| May 12, 2026 | Ware J. Anthony | Director | grant | 15,000 | — | — | 4 on EDGAR |
| May 12, 2026 | Faga Daniel | President, CEO | grant | 100,200 | — | — | 4 on EDGAR |
| May 12, 2026 | Jain Rita | Director | grant | 15,000 | — | — | 4 on EDGAR |
| May 12, 2026 | FENTON DENNIS M | Director | grant | 15,000 | — | — | 4 on EDGAR |
| May 12, 2026 | Tamboli Ajim | Chief Financial Officer | grant | 5,000 | — | — | 4 on EDGAR |
| May 12, 2026 | Schmid John P. | Director | grant | 2,500 | — | — | 4 on EDGAR |
| May 12, 2026 | STONE BENJAMIN | Chief Business Officer | grant | 26,700 | — | — | 4 on EDGAR |
| May 12, 2026 | Lizzul Paul F. | Chief Medical Officer | grant | 26,700 | — | — | 4 on EDGAR |
| May 12, 2026 | Marquet Magda | Director | grant | 2,500 | — | — | 4 on EDGAR |
| May 12, 2026 | Orwin John A | Director | grant | 15,000 | — | — | 4 on EDGAR |
| May 12, 2026 | Marquet Magda | Director | grant | 15,000 | — | — | 4 on EDGAR |
| May 12, 2026 | Schmid John P. | Director | grant | 15,000 | — | — | 4 on EDGAR |
| Apr 21, 2026 | Tamboli Ajim | Chief Financial Officer | grant | 45,700 | — | — | 4 on EDGAR |
| Apr 20, 2026 | ANAPTYSBIO, INC | 10% owner | other | 100 | — | — | 4 on EDGAR |
| — | STONE BENJAMIN | Chief Business Officer | — | — | — | — | 3 on EDGAR |
| Apr 20, 2026 | Ware J. Anthony | Director | grant | 28,571 | — | — | 4 on EDGAR |
| Apr 20, 2026 | Jain Rita | Director | grant | 10,600 | — | — | 4 on EDGAR |
| Apr 20, 2026 | Marquet Magda | Director | grant | 784 | — | — | 4 on EDGAR |
| Apr 20, 2026 | FENTON DENNIS M | Director | grant | 6,000 | — | — | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Get the data
Query TRAX context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access